We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.19%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$10.7B
AUM Growth
+$2.52B
(+31%)
Cap. Flow
+$2.21B
Cap. Flow
% of AUM
20.71%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
1,276
New
389
Increased
311
Reduced
230
Closed
325
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$119M |
| 2 |
Perrigo
PRGO
|
+$108M |
| 3 |
Microsoft
MSFT
|
+$107M |
| 4 |
Zoetis
ZTS
|
+$84.7M |
| 5 |
Viatris
VTRS
|
+$78.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$73.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$67.8M |
| 3 |
Meta Platforms (Facebook)
META
|
+$66.6M |
| 4 |
Nike
NKE
|
+$57.9M |
| 5 |
AutoZone
AZO
|
+$54.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.92% |
| 2 | Communication Services | 13.85% |
| 3 | Financials | 12.23% |
| 4 | Industrials | 12.2% |
| 5 | Consumer Discretionary | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VWR
201
DELISTED
VWR Corporation
VWR
| $12M | 0.11% |
424,969
+415,970
| +4,622% | +$11M |
|
|
EMC
202
DELISTED
EMC CORPORATION
EMC
| $11.6M | 0.11% |
451,303
+144,799
| +47% | +$3.76M |
|
|
LOGM
203
DELISTED
LogMein, Inc.
LOGM
| $11.4M | 0.11% |
169,519
-197,723
| -54% | -$13.8M |
|
204
Eaton
ETN
$174B
| $11.3M | 0.11% |
216,638
+107,057
| +98% | +$5.8M |
|
|
PRAH
205
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.2M | 0.1% |
246,621
-8,677
| -3% | -$365K |
|
|
KSU
206
DELISTED
Kansas City Southern
KSU
| $11.2M | 0.1% |
149,487
+143,351
| +2,336% | +$12.2M |
|
207
Altria Group
MO
$114B
| $11.1M | 0.1% |
+190,580
| New | +$11M |
|
208
Synchrony
SYF
$25.8B
| $11M | 0.1% |
+363,223
| New | +$11.4M |
|
|
QTS
209
DELISTED
QTS REALTY TRUST, INC.
QTS
| $11M | 0.1% |
+244,560
| New | +$10.6M |
|
210
Valero Energy
VLO
$87.1B
| $11M | 0.1% |
155,218
+97,465
| +169% | +$6.64M |
|
|
KITE
211
DELISTED
Kite Pharma, Inc.
KITE
| $10.9M | 0.1% |
+177,311
| New | +$12.5M |
|
|
BLUE
212
DELISTED
bluebird bio
BLUE
| $10.8M | 0.1% |
13,003
+10,265
| +375% | +$10.3M |
|
213
Devon Energy
DVN
$48.5B
| $10.8M | 0.1% |
337,566
+242,802
| +256% | +$9.96M |
|
|
VIAB
214
DELISTED
Viacom Inc. Class B
VIAB
| $10.8M | 0.1% |
262,223
+229,559
| +703% | +$10.8M |
|
215
L3Harris
LHX
$53.3B
| $10.7M | 0.1% |
123,030
+26,630
| +28% | +$2.14M |
|
|
ACHN
216
DELISTED
Achillion Pharmaceuticals
ACHN
| $10.5M | 0.1% |
970,862
+261,007
| +37% | +$2.37M |
|
|
CTXS
217
DELISTED
Citrix Systems Inc
CTXS
| $10.3M | 0.1% |
170,770
+57,565
| +51% | +$3.53M |
|
218
RB Global
RBA
$17.7B
| $10.2M | 0.1% |
424,371
+285,365
| +205% | +$7.32M |
|
|
MSGN
219
DELISTED
MSG Networks Inc.
MSGN
| $10.2M | 0.1% |
+489,246
| New | +$9.95M |
|
220
Dycom Industries
DY
$12.3B
| $10.1M | 0.09% |
+144,050
| New | +$11.4M |
|
221
Lowe's Companies
LOW
$123B
| $10.1M | 0.09% |
132,263
+125,392
| +1,825% | +$9.31M |
|
|
INVX
222
Innovex International
INVX
$2.13B
| $10M | 0.09% |
169,350
+132,530
| +360% | +$8.22M |
|
223
Micron Technology
MU
$1.01T
| $9.99M | 0.09% |
705,405
+663,008
| +1,564% | +$10.6M |
|
224
PPG Industries
PPG
$26.5B
| $9.93M | 0.09% |
100,503
-508,438
| -83% | -$51.4M |
|
225
Coca-Cola Europacific Partners
CCEP
$48B
| $9.9M | 0.09% |
201,147
-139,406
| -41% | -$7.02M |
|
Similar funds
Marshall Wace's Q4 2015 Portfolio in Review
As of Q4 2015, Marshall Wace held 1,276 positions worth $10.7B, up 31% from $8.14B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace deployed $2.21B of net new capital in Q4 2015, opening 389 new positions and adding to 311 existing holdings. Its largest new stake was The Mosaic Company: 1,613,517 shares worth $44.5M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Sherwin-Williams, an estimated $73.7M trimmed.
- Marshall Wace's largest Q4 2015 buy was The Mosaic Company: 1,613,517 shares worth $44.5M.
- Marshall Wace added most to Bristol-Myers Squibb in Q4 2015, an estimated $119M increase.
- Marshall Wace's biggest Q4 2015 reduction was Sherwin-Williams, cutting an estimated $73.7M.
- Marshall Wace fully exited HOME PROPERTIES, INC in Q4 2015, selling an estimated $40.2M.
- Marshall Wace's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2015.
- Marshall Wace opened 389 new positions and closed 325 in Q4 2015.
- Marshall Wace's portfolio value rose 31% quarter-over-quarter to $10.7B.
Based on Marshall Wace's 13F filing for Q4 2015, filed 10 Feb 2016.